January 10, 2022 WASHINGTON, D.C., and SAN FRANCISCO, Calif. - Accelerate Brain Cancer Cure (ABC2 ) announced today that Kate Carr, former president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, has been named president and CEO. Ms. Carr replaces John Reher, who will move to the investment sector, where he will pursue private equity efforts to advance and accelerate the work of innovative companies developing treatments for brain diseases.

Steve Case, chairman and CEO of Revolution and chairman of ABC2, gave a presentation on a broad range of health issues during the JPMorgan Healthcare Conference on January 10, 2022 in San Francisco, California. During his keynote presentation at the Westin St. Francis Hotel, Mr. Case stated, "Under John's leadership, ABC2 has brought an entrepreneurial spirit and approach to cancer research, the success of which can be measured by the number of potential new therapies the organization has helped advance into clinical development. We look forward to continuing to work with him in his new endeavors."

Mr. Case continued, "We are thrilled to have a new leader of Kate's caliber. Her passion for our mission and her experience building partnerships as an advocate in the nonprofit and government sectors will be invaluable as we intensify our efforts to hasten a cure for brain cancer."

Ms. Carr said, "Brain cancer is one of the last great challenges in cancer research. Leading ABC2 is a tremendous opportunity to collaborate with the best and brightest minds in the field - including researchers at academic medical centers, NIH, FDA, and industry."

Ms. Carr brings a wealth of experience in politics, government, and public-private partnerships. Before serving at the Elizabeth Glaser Pediatric AIDS Foundation for seven years, she was chief operating officer for the Welfare to Work Partnership and a special assistant to the president in the Clinton White House, overseeing outreach and partnerships with the business community.